Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention
Launched by YALE UNIVERSITY · Jul 11, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention is a clinical trial aimed at improving asthma care for children in the New Haven area. The study focuses on creating a partnership between local community resources and healthcare providers to offer better support for kids with asthma. It includes an online tool to help families understand asthma triggers and a program that connects families with health workers who provide culturally sensitive support, along with legal and medical services. The goal is to make it easier for families to manage asthma and reduce related health issues.
To participate, children aged 1 to 17 with a diagnosis of asthma may be eligible if they have experienced certain problems in the past year, such as needing oral steroids, visiting the emergency room, or having asthma attacks. They should also be living in the New Haven area. Participants can expect to receive education about asthma management and support tailored to their needs. This trial is currently recruiting participants and aims to help improve asthma outcomes for children in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Children with a diagnosis of asthma with at least one of the following:
- • Oral steroid prescription in past 12m
- • ED visit for asthma in past 12m
- • Hospital admission for asthma in past 12m
- • Asthma control test (ACT) score at visit ≤19
- • Concern for asthmogenic exposure in the home (such as mold, pests, smoking, or pollution)
- • At least one missed follow-up appointment for asthma
- • At least one asthma exacerbation in the prior year
- • Interested in asthma education (such as education in how to prevent asthma or how to administer medications)
- • Concern for medication non-adherence
- Exclusion Criteria:
- • Living outside of New Haven Zip Code
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Julia Rosenberg, MD MHS
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported